These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3055210)

  • 21. Differential release of an immunodominant 65 kDa mannoprotein antigen from yeast and mycelial forms of Candida albicans.
    Bromuro C; Torosantucci A; Gomez MJ; Urbani F; Cassone A
    J Med Vet Mycol; 1994 Dec; 32(6):447-59. PubMed ID: 7738727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The 65 kDa mannoprotein gene of Candida albicans encodes a putative beta-glucanase adhesin required for hyphal morphogenesis and experimental pathogenicity.
    Sandini S; La Valle R; De Bernardis F; Macrì C; Cassone A
    Cell Microbiol; 2007 May; 9(5):1223-38. PubMed ID: 17217426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary characterization of the material released to the culture medium by Candida albicans yeast and mycelial cells.
    López-Ribot JL; Gozalbo D; Sepúlveda P; Casanova M; Martínez JP
    Antonie Van Leeuwenhoek; 1995 Oct; 68(3):195-201. PubMed ID: 8572676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Candida albicans exocellular antigens released into a synthetic culture medium: characterization and serological response in rabbits.
    Aguiar JM; Baquero F; Jones JM
    J Gen Microbiol; 1993 Dec; 139(12):3005-10. PubMed ID: 8126426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dimorphism in Candida albicans: contribution of mannoproteins to the architecture of yeast and mycelial cell walls.
    Elorza MV; Murgui A; Sentandreu R
    J Gen Microbiol; 1985 Sep; 131(9):2209-16. PubMed ID: 3906035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of cytoplasmic antigens of the yeast and mycelial phases of Candida albicans by two-dimensional electrophoresis.
    Manning M; Mitchell TG
    Infect Immun; 1980 Nov; 30(2):484-95. PubMed ID: 7002799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced expression of the functionally active complement receptor for iC3b but not for C3d on an avirulent mutant of Candida albicans.
    Ollert MW; Wadsworth E; Calderone RA
    Infect Immun; 1990 Apr; 58(4):909-13. PubMed ID: 2138588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactivity of Candida albicans germ tubes with salivary secretory IgA.
    Pontón J; Bikandi J; Moragues MD; Arilla MC; Elósegui R; Quindós G; Fisicaro P; Conti S; Polonelli L
    J Dent Res; 1996 Dec; 75(12):1979-85. PubMed ID: 9033453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of antigenicity of Candida albicans growth phases to diagnosis of systemic candidiasis.
    Evans EG; Richardson MD; Odds FC; Holland KT
    Br Med J; 1973 Oct; 4(5884):86-7. PubMed ID: 4200829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenemia in rabbits infected with Candida albicans serotype B: detection by enzyme immunoassay and preliminary characterization of the antigen.
    Reiss E; Kuykendall RJ; Kaufman L
    J Med Vet Mycol; 1986 Aug; 24(4):259-69. PubMed ID: 3528447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A crossreactivity at the immunoglobulin E level of the cell wall mannoproteins of Candida albicans with other pathogenic Candida and airborne yeast species.
    Kanbe T; Utsunomiya K; Ishiguro A
    Clin Exp Allergy; 1997 Dec; 27(12):1449-57. PubMed ID: 9433941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cytologic analysis of the expression of an epitope carried by glycoproteins excreted by Candida albicans].
    Cailliez JC; Poulain D
    Ann Inst Pasteur Microbiol; 1988; 139(2):171-88. PubMed ID: 2457385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variations in the antigenic effects of tunicamycin on Candida albicans.
    Vespa MN; Lebecq JC; Simonetti N; Bastide JM
    Comp Immunol Microbiol Infect Dis; 1993 Apr; 16(2):163-72. PubMed ID: 8319438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Quantitative immunoelectrophoretic methods applied to the immunochemistry of Candida].
    Guinet R; Gabriel S
    C R Seances Soc Biol Fil; 1980; 174(3):325-34. PubMed ID: 6448676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adherence and receptor relationships of Candida albicans.
    Calderone RA; Braun PC
    Microbiol Rev; 1991 Mar; 55(1):1-20. PubMed ID: 2030668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Candida albicans fibrinogen binding mannoprotein: expression in clinical strains and immunogenicity in patients with candidiasis.
    Sepúlveda P; López-Ribot JL; Murgui A; Cantón E; Navarro D; Martínez JP
    Int Microbiol; 1998 Sep; 1(3):209-16. PubMed ID: 10943362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Candida albicans group A-specific soluble antigens demonstrated by quantitative immunoelectrophoresis.
    Guinet RM; Gabriel SM
    Infect Immun; 1980 Sep; 29(3):853-8. PubMed ID: 6159327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall.
    Vecchiarelli A; Puliti M; Torosantucci A; Cassone A; Bistoni F
    Cell Immunol; 1991 Apr; 134(1):65-76. PubMed ID: 1672836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KRE5 gene null mutant strains of Candida albicans are avirulent and have altered cell wall composition and hypha formation properties.
    Herrero AB; Magnelli P; Mansour MK; Levitz SM; Bussey H; Abeijon C
    Eukaryot Cell; 2004 Dec; 3(6):1423-32. PubMed ID: 15590817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Protein and antigenic spectrum of different species of yeasts of the genus Candida].
    Mishneavskĭ NV; Tsinberg MB; Obvintsev VK
    Zh Mikrobiol Epidemiol Immunobiol; 1976; (12):91-4. PubMed ID: 66829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.